CSANZ > News Archive > Congratulations to the CSANZ 2021 Prizewinners
ALLIED HEALTH SCIENCE, TECHNOLOGY PRIZE
Ingrid Stacey, University of WA
Abstract: Long-term outcomes after RHD diagnosis in Australia: a linked data study.
Judges: Leah Wright, Stephanie Partridge
CARDIOVASCULAR GENETICS PRIZE
Stacey Peters, Royal Melbourne Hospital, VIC
Abstract: Arrhythmias are a Requisite Feature of SCN5A Mediated Dilated Cardiomyopathy : A Systematic Review of Variants
Judges: Jon Skinner, Kathryn Waddell-Smith
CARDIAC IMAGING PRIZE
Siddharth Trivedi, Westmead Hospital, NSW
Speckle tracking echocardiography predicts arrhythmia recurrence in patients with structural heart disease following ventricular tachycardia ablation.
Judges: Sudhir Wahi, Angeline Leet
CARDIOVASCULAR NURSING PRIZE
Lynda Tivendale, Royal Melbourne Hospital, VIC
Multimodal lung and sternal ultrasound education program for cardiothoracic nurses and physiotherapists.
Judges: Robyn Clarke, Jan Cameron, Judith Finn
HEART FAILURE PRIZE
Praveen Indraratna, Prince of Wales Hospital, NSW
TeleClinical Care: A randomised control trial of a smartphone-based model of care for patients with heart failure or acute coronary syndrome.
Judges: Mayanna Lund, Aaron Sverdlov
HEART RHYTHM PRIZE
Varun Malik, Royal Adelaide Hospital, SA
AF begets autonomic nervous system dysfunction: a possible contributor to “AF begets AF”.
Judges: Saurabh Kumar, Martin Stiles
INDIGENEOUS HEALTH PRIZE
Katharine McBride, SAHMRI, SA
When the heart is spiritually and physically strong, women have lower incident cardiovascular disease: Quantifying Aboriginal women’s narrative of cardiovascular protection.
Judges: Judith Katzenellenbogen, William Wang
PAEDIATRIC AND CONGENITAL CARDIOLOGY PRIZE
Karina Laohachai, Women’s and Children’s Hospital, SA
Older age of Fontan completion is associated with impaired lung function.
Judges: Michael Cheung, Mugur Nicolae
PREVENTATIVE CARDIOLOGY PRIZE
Kasun De Silva, Westmead Hospital, NSW
Sex-based differences in implantation of pacemakers, implantable cardioverter defibrillators and cardiac resynchronisation therapy: a 10-year study of 1,291,258 patients in New South Wales.